Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Amneal Pharmaceuticals

Tracked across 6 events · 142 articles · First seen Apr 22, 2026 · Last active Sep 18, 2026

Sentiment
35
Attention
7
Events
6
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
0 0
Business
Impact: Amneal is the subject of the earnings date announcement; the event itself is neutral.
Jul 09, 2026 · 6 articles
2 40
Regulatory
Impact: Amneal received FDA approval for additional iohexol injection presentations, expanding its contrast portfolio and positioning it to capture a larger share of the U.S. market.
Jul 17, 2026 · 7 articles
2 60
Regulatory
Amneal Pharmaceuticals received U.S. United States — Food and Drug Administration approval for its lanreotide injection, 120 mg/0.5 mL, a generic version of Somatuline Depot, and launched the product immediately. The approval carries Competitive Generic…
Impact: Amneal secured FDA approval and immediate launch of generic lanreotide, adding a material growth driver to its complex injectables portfolio and lifting its shares 2.35%.
Sep 18, 2026 · 6 articles
4 60
International
Impact: Amneal Pharmaceuticals' Co-Founder & Co-CEO met with Piyush Goyal to explore investment opportunities in India's pharmaceutical sector and avenues for deeper collaboration in R&D.
May 29, 2026 · 8 articles
7 50
International
Impact: Amneal Pharmaceuticals>>> discussed investment opportunities in India>>>'s pharmaceutical sector and avenues for deeper collaboration with Piyush Goyal>>>.
May 21, 2026 · 109 articles
4 0
Business
Apr 22, 2026 · 6 articles
Chintu Patel ↔ Amneal Pharmaceuticals
Chintu Patel co-ceo ↔ Amneal Pharmaceuticals Chintu Patel is the co-founder and current Co-Chief Executive Officer of Amneal
ERGEN INTELLIGENCE
Track Amneal Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.